Stay updated with breaking news from Research Engine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Second Quarter 2023 Total Revenue of $38.3 Million; Net Product Revenue for QINLOCK® (ripretinib) Increased 18% to $37.3 Million Compared to Second Quarter 2022 –– Top-line Results for MOTION Pivotal Phase 3 Study of Vimseltinib Expected in Fourth Quarter 2023 –– INSIGHT Pivotal Phase 3 Study of QINLOCK in Second-...
/PRNewswire/ -- In an era of rapid change, brands must be swift, adaptable, and insightful to succeed. Current research and insights approaches fail to deliver...
Jun 22, 2023 (Heraldkeepers) -- The global Particle Treatment Devices market report provides geographic analysis covering regions, such as North America,...
Jun 22, 2023 (Heraldkeepers) -- The Positive Air Pressure Devices Market is expected to grow at a CAGR of 8% during the forecasting period. A positive air...
Jun 20, 2023 (Heraldkeepers) -- The Non-Small Cell Lung Cancer Market is likely to grow at a rate of 9.2% CAGR by 2028. Market Research Engine has published...